MTHFR C677T and A1298C polymorphisms and cervical carcinoma susceptibility: meta-analyses based on 4421 individuals

Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

Gadducci A, Barsotti C, Cosio S, Domenici L, Riccardo Genazzani A (2011) Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature. Gynecol Endocrinol 27:597–604

Wattleworth R (2011) Human papillomavirus infection and the links to penile and cervical cancer. J Am Osteopath Assoc 111:S3–10

Gao LB, Pan XM, Li LJ et al (2011) Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis. PLoS One 6:e20157

Ding B, Fu S, Wang M et al (2011) Tumor Necrosis Factor alpha −308 G>A polymorphisms and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer 22(2):213–219

Li Y, Liu F, Tan S, Li S (2011) P21 Ser31Arg polymorphism and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer 21:445–451

Klug SJ, Ressing M, Koenig J et al (2009) TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol 10:772–784

Ni J, Wang M, Fu S et al (2011) CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis. J Cancer Res Clin Oncol 137:489–494

James SJ, Pogribny IP, Pogribna M et al (2003) Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis. J Nutr 133:3740S–3747S

Duthie SJ, Narayanan S, Sharp L et al (2004) Folate, DNA stability and colo-rectal neoplasia. Proc Nutr Soc 63:571–578

Kim YI (2009) Role of the MTHFR polymorphisms in cancer risk modification and treatment. Future Oncol 5:523–542

Toffoli G, De Mattia E (2008) Pharmacogenetic relevance of MTHFR polymorphisms. Pharmacogenomics 9:1195–1206

Rozen R (1997) Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost 78:523–526

De Mattia E, Toffoli G (2009) C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation. Eur J Cancer 45:1333–1351

Munafo MR, Clark TG, Flint J (2004) Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. Psychiatry Res 129:39–44

Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

Zoodsma M, Nolte IM, Te Meerman GJ, De Vries EG, Van der Zee AG (2005) HLA genes and other candidate genes involved in susceptibility for (pre)neoplastic cervical disease. Int J Oncol 26:769–784

Powers HJ (2005) Interaction among folate, riboflavin, genotype, and cancer, with reference to colorectal and cervical cancer. J Nutr 135:2960S–2966S

Piyathilake CJ, Macaluso M, Johanning GL et al (2000) Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res 20:1751–1757

Goodman MT, McDuffie K, Hernandez B et al (2001) Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 10:1275–1280

Agodi A, Barchitta M, Cipresso R et al (2010) Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in sicily. Int J Gynecol Cancer 20:141–146

Piyathilake CJ, Azrad M, Macaluso M et al (2007) Protective association of MTHFR polymorphism on cervical intraepithelial neoplasia is modified by riboflavin status. Nutrition 23:229–235

Kim K, Kang SB, Chung HH et al (2008) XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer. Gynecol Oncol 111:509–515

Gerhard DS, Nguyen LT, Zhang ZY et al (2003) A relationship between methylenetetrahydrofolate reductase variants and the development of invasive cervical cancer. Gynecol Oncol 90:560–565

Rao GG, Kurien A, Gossett D et al (2006) A case-control study of methylenetetrahydrofolate reductase polymorphisms in cervical carcinogenesis. Gynecol Oncol 101:250–254

Nandan NK, Wajid S, Biswas S et al (2008) Allelic variations in 5, 10-methylenetetrahydrofolate reductase gene and susceptibility to cervical cancer in Indian women. Drug Metab Lett 2:18–22

Yang F, Zhou Y, Jiang Y, Fan Y, Li J (2011) Study on the correlation between polymorphism of MTHFR gene and pathogenesis of cervical cancer. Maternal and Child Health Care of China 26:4087–4089

Tong SY, Lee JM, Song ES et al (2010) The effects of polymorphisms in methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), and methionine synthase reductase (MTRR) on the risk of cervical intraepithelial neoplasia and cervical cancer in Korean women. Cancer Causes Control 21:23–30

Tong SY, Kim MK, Lee JK et al (2011) Common polymorphisms in methylenetetrahydrofolate reductase gene are associated with risks of cervical intraepithelial neoplasia and cervical cancer in women with low serum folate and vitamin B12. Cancer Causes Control 22:63–72

Lambropoulos AF, Agorastos T, Foka ZJ et al (2003) Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia. Cancer Lett 191:187–191

Sull JW, Jee SH, Yi S et al (2004) The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women. Gynecol Oncol 95:557–563

Kang S, Kim JW, Kang GH et al (2005) Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol 96:173–180

Zoodsma M, Nolte IM, Schipper M et al (2005) Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for (pre)neoplastic cervical disease. Hum Genet 116:247–254

Delgado-Enciso I, Martinez-Garza SG, Rojas-Martinez A et al (2006) The effect of MTHFR polymorphisms, pregnancy and first intercourse on cervical cancer in a population from the Northeastern Mexico. Rev Invest Clin 58:462–469

Ma X, Wang J, Zhou Q et al (2006) Relationship between methylenetetrahydrofolate reductase polymorphism and cervical cancer susceptibility. Chin J Public Health 22:1427–1428

Shekari M, Sobti RC, Kordi Tamandani DM, Suri V (2008) Impact of methylenetetrahydrofolate reductase (MTHFR) codon (677) and methionine synthase (MS) codon (2756) on risk of cervical carcinogenesis in North Indian population. Arch Gynecol Obstet 278:517–524

Kohaar I, Kumar J, Thakur N et al (2010) Homocysteine levels are associated with cervical cancer independent of methylene tetrahydrofolate reductase gene (MTHFR) polymorphisms in Indian population. Biomarkers 15:61–68

Mostowska A, Myka M, Lianeri M, Roszak A, Jagodzinski PP (2011) Folate and choline metabolism gene variants and development of uterine cervical carcinoma. Clin Biochem 44:596–600

Prasad VV, Wilkhoo H (2011) Association of the functional polymorphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian, and cervical cancers. Onkologie 34:422–426

Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Techn Bull 8:15–17

Rossmanith P, Mester P, Fruhwirth K, Fuchs S, Wagner M (2011) Proof of concept for recombinant cellular controls in quantitative molecular pathogen detection. Appl Environ Microbiol 77:2531–2533

Qi X, Ma X, Yang X et al (2010) Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls. Breast Cancer Res Treat 123:499–506

Mazaki T, Masuda H, Takayama T (2011) Polymorphisms and pancreatic cancer risk: a meta-analysis. Eur J Cancer Prev 20:169–183

Dong X, Wu J, Liang P et al (2010) Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer: a meta-analysis. Arch Med Res 41:125–133

Jin F, Qu LS, Shen XZ (2009) Association between the methylenetetrahydrofolate reductase C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis. Diagn Pathol 4:39

Bai JL, Zheng MH, Xia X et al (2009) MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: a meta-analysis of 3511 cases and 2762 controls. Eur J Cancer 45:1443–1449

Taioli E, Garza MA, Ahn YO et al (2009) Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Am J Epidemiol 170:1207–1221

Qiu LX, Zhang J, Li WH et al (2011) Lack of association between methylenetetrahydrofolate reductase gene A1298C polymorphism and breast cancer susceptibility. Mol Biol Rep 38:2295–2299

Kim YI, Pogribny IP, Basnakian AG et al (1997) Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am J Clin Nutr 65:46–52

Kamen B (1997) Folate and antifolate pharmacology. Semin Oncol 24:S18-30–S18-39

Novakovic P, Stempak JM, Sohn KJ, Kim YI (2006) Effects of folate deficiency on gene expression in the apoptosis and cancer pathways in colon cancer cells. Carcinogenesis 27:916–924

Lee HY, Ju E, Vang PD, Lundquist M (2010) Breast and cervical cancer screening among Asian American women and Latinas: does race/ethnicity matter? J Womens Health (Larchmt) 19:1877–1884

Coker AL, Eggleston KS, Du XL, Ramondetta L (2009) Ethnic disparities in cervical cancer survival among Medicare eligible women in a multiethnic population. Int J Gynecol Cancer 19:13–20